Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Roxgold Inc. T.ROXG

Roxgold Inc is a Canadian gold mining company. It is engaged in acquiring and exploring mineral properties. The company has two reportable segments; Mining operations and Exploration and evaluation of mineral properties, located in Burkina Faso. Its key asset is the Yaramoko Gold Mine, located in the Hounde greenstone belt of Burkina Faso, West Africa, and Seguela Gold Project located in Cote d... see more

Recent & Breaking News (TSX:ROXG)

Roche gains FDA Clearance for 18-Minute Anti-Müllerian Hormone Test to Assess Ovarian Reserve

PR Newswire January 5, 2017

FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization

Business Wire January 5, 2017

Roche launches cobas® c 513 analyzer and HbA1c Gen. 3 assay to meet increasing demand for testing of people with diabetes

PR Newswire January 4, 2017

Roche launches cobas® CT/NG on the cobas® 6800/8800 Systems in markets accepting the CE mark

PR Newswire Europe Non Regulatory December 22, 2016

Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study

Business Wire December 22, 2016

Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS™ (Ocrelizumab) Published in New England Journal of Medicine

Business Wire December 21, 2016

FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)

Business Wire December 20, 2016

Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences

PR Newswire December 15, 2016

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer

Business Wire December 6, 2016

Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in the United States

PR Newswire December 5, 2016

Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared to Rituxan

Business Wire December 4, 2016

Roche expands distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany to include Kapa Biosystems qPCR and endpoint PCR Portfolios

PR Newswire Europe Non Regulatory December 1, 2016

Roxgold Intersects 20.1 Grams per Tonne of Gold over 23.8 Metres in Step-out Drilling at Zone 55

Canada NewsWire November 29, 2016

Roche launches DISCOVERY 5-Plex procedure for cancer research applications

PR Newswire Europe Non Regulatory November 21, 2016

Roxgold reports financial results for period ended September 30, 2016

Canada NewsWire November 14, 2016

Roxgold to Release Third Quarter Results on November 14, 2016

Canada NewsWire October 25, 2016

Roxgold produces 32,987 ounces of gold during the third quarter and declares commercial production at Yaramoko gold mine in Burkina Faso

Canada NewsWire October 4, 2016

Roxgold Provides Production & Operations Update at Yaramoko

Canada NewsWire September 12, 2016

Roxgold Announces Positive Results from Definition Program at Zone 55

Canada NewsWire August 31, 2016

Roxgold Grants Deferred Share Units, Restricted Share Units and Stock Options

Canada NewsWire August 22, 2016